/ /

  • linkedin
  • Increase Font
  • Sharebar

    Technologic advances integrate OCT into real-time surgeries

    Three devices in DISCOVER study show benefit of integrated approach, but barriers remain

    Take-home message: Researchers are conducting a prospective, multisurgeon, single-center study to evaluate multiple microscope integrated-prototypes with real-time surgeon feedback.

     

    Cleveland—Microscope integrated intraoperative optical coherence tomography (iOCT) can confirm that surgical objectives of various retina surgeries have been met, said Justis P. Ehlers, MD.

    Dr. Ehlers and colleagues are conducting a prospective, multisurgeon, single-center study, the DISCOVER study, to evaluate multiple microscope integrated-prototypes with real-time surgeon feedback, including the Rescan 700 (Carl Zeiss Meditec), the Bioptigen prototype (Leica), and a Cole Eye Institute iOCT System (Cleveland, OH).

    Simple solution for presbyopia?

    The Rescan 700 is based on the Lumera 700 platform (Carl Zeiss Meditec). The device received FDA clearance in late 2014, and is only one of two devices studied that currently has regulatory clearance in the United States. (The second FDA -cleared device, the iOCT from Optomedical Technologies integrated into the HS Hi-R Neo 900A (Haag-Streit Surgical) was not included as part of this study.)

    How the technologies differ

    Two of the devices—the Cole Eye Institute iOCT system and the Rescan—utilize a heads-up display system.

    The Rescan is a single integrated system, with both the microscope and OCT integrated into one unit.

    Next: Advantages, disadvantages

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results